Current posture

What matters now

The Cannabist Company’s U.S. Chapter 15 case remains a cross-border adjunct to its Canadian CCAA restructuring and asset-sale wind-down; the scheduled August 20 hearing on U.S. enforcement of Canadian collateral-proceeds relief was cancelled after the debtor reported that the requested relief had been granted, with no objections or responses received. Notice cancelling the cash-collateral hearing Dkt. 104 The parent and its Canadian affiliate commenced the Canadian CCAA proceeding and, on March 25, 2026, sought Chapter 15 recognition in Delaware as a foreign main proceeding (or, alternatively, a nonmain proceeding), together with U.S. stay and related relief. Chapter 15 petition Dkt. 1 The filing followed a missed January 30 interest payment under the senior notes and a capital structure of approximately $220 million in funded debt, including senior secured notes and East West Bank mortgage obligations. Recognition motion Dkt. 5 The debtors framed the restructuring as an orderly monetization of their U.S. cannabis operations: a sale process run with Moelis had produced a completed Virginia sale, signed Ohio and Delaware transactions, and a completed Mission Bay sale, while an ad hoc…

Updated Aug 20, 2026